Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103224963A reveals a marine strain method for high-purity chiral amines. Discover cost reduction in pharmaceutical intermediates manufacturing and scalable biocatalysis.
Patent CN107286203B details a novel route for chiral Ugi's amine. Discover cost-effective manufacturing and supply chain advantages for Josiphos ligands.
Patent CN105712812A reveals high-efficiency chiral amine synthesis. Offers significant cost reduction and supply chain reliability for global pharmaceutical intermediates manufacturing processes.
Patent CN119913221A reveals enzymatic route for ACEI intermediates. Offers high stereoselectivity and cost reduction in pharmaceutical intermediate manufacturing supply chains.
Patent CN118291412A reveals a novel Leucine Dehydrogenase for efficient L-Phosphinothricin and L-Phenylglycine synthesis, offering significant cost reduction and supply chain reliability.
Discover a novel synthesis route for trans-4-Boc-aminocyclohexanecarboxylic acid via patent CN113402428A. Achieve >95% stereoselectivity and streamlined manufacturing for peptide drugs.
Patent CN104447791B reveals a low-cost D-biotin preparation method. Discover supply chain advantages and high-purity manufacturing capabilities for global procurement.
Novel aminotransferase patent enables high-purity sitagliptin intermediate production with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN110551032B details a high-efficiency iridium-catalyzed asymmetric reductive amination method, offering significant cost reduction in agrochemical manufacturing and reliable supply chain solutions.
Discover high-purity indole-dihydronaphthalene intermediates via novel Rh/Pd dual catalysis. Enhanced enantioselectivity and cost-effective manufacturing for pharma.
Patent CN114349648A details a one-step ruthenium-catalyzed reductive amination for high-purity chiral amines, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103224963B reveals marine strain catalysis for high-purity chiral amines. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102766058A details a novel organocatalytic route for photoactive alpha-amino acids, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN110577941B reveals mutated enzymes for high-purity chiral amine synthesis, offering cost reduction in pharmaceutical intermediate manufacturing via biocatalysis.
Patent CN110734378B reveals a mild Ni-catalyzed method for high-ee chiral allylamines. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN104829460A reveals a cost-effective asymmetric reductive amination route for cinacalcet hydrochloride, offering high purity and scalable pharmaceutical intermediate manufacturing solutions.
Discover advanced Pd-catalyzed synthesis for chiral beta-lactams. High enantioselectivity and scalable processes for reliable pharmaceutical intermediates supply chains.
Patent CN105039450A reveals one-step enzymatic route. High purity, scalable process for reliable pharmaceutical intermediate supplier partners seeking significant cost reduction and efficiency.
Patent CN112300047A reveals a novel Ru-catalyzed tandem reductive amination for chiral lactams, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN105734089A reveals enzymatic synthesis for pharmaceutical intermediates. Offers high optical purity and scalable production for global supply chains.